Bal Pharma Limited
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Bal Pharma Limited generated cash of $228,058,000, which is more than the previous year. Cash used in financing activities reached the amount of -$12,063,000 last year. Net change in cash is therefore $27,087,000.
Cash Flow
| 2010 | -51.81M | 46.06M | 7.42M |
|---|---|---|---|
| 2011 | 46.08M | -15.93M | -23.99M |
| 2012 | 128.58M | -22.21M | -95.77M |
| 2016 | -193.53M | -138.81M | 323.74M |
| 2018 | -4.96M | -35.63M | 35.46M |
| 2020 | 231.01M | -47.05M | -199.73M |
| 2021 | 217.81M | -49.80M | -166.32M |
| 2023 | -18.43M | -221.82M | 244.00M |
| 2024 | 228.05M | -188.90M | -12.06M |
BALPHARMA.NS Cash Flow Statement (2010 – 2023)
| 2023 | 2022 | 2020 | 2019 | 2017 | 2015 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 14.87M | 11.12M | 8.58M | 24.36M | -253.03M | 54.94M | 19.67M | 16.14M | 14.47M |
Operating activities | |||||||||
Net income | 73.92M | 47.48M | 41.02M | -135.29M | 28.83M | 26.49M | 37.56M | 0 | 0 |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||||
Depreciation and amortization | 100.71M | 91.28M | 95.21M | 76.77M | 67.71M | 70.09M | 41.30M | 29.00M | 28.07M |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | |||||||||
Accounts receivable, net | -142.93M | -398.42M | -185M | 134.67M | -31.31M | -119.58M | 0 | 0 | 0 |
Inventories | 101.93M | -236.09M | 73.26M | 20.39M | -117.62M | -59.39M | -14.45M | -35.91M | -46.85M |
Accounts payable | -5.95M | 269.05M | 89.80M | -87.52M | -44.67M | 83.16M | 0 | 0 | 0 |
Cash generated by operating activities | 228.05M | -18.43M | 217.81M | 231.01M | -4.96M | -193.53M | 128.58M | 46.08M | -51.81M |
Investing activities | |||||||||
Purchases Of Investments | 0 | -8.10M | -9.11M | 0 | 0 | 0 | -100K | 0 | 0 |
Investments In Property Plant And Equipment | -109.8M | -146.45M | -34.13M | -50.63M | -37.82M | -142.05M | -36.34M | -14.66M | -12.92M |
Acquisitions Net | 0 | -68.66M | -9.79M | 184K | 0 | 199.99K | 0 | 0 | 0 |
Cash generated by investing activities | -188.90M | -221.82M | -49.80M | -47.05M | -35.63M | -138.81M | -22.21M | -15.93M | 46.06M |
Financing activities | |||||||||
Common Stock Issued | 5.01M | 39.17M | 41.87M | 0 | 0 | 200M | 0 | 0 | 0 |
Payments for dividends | -15.69M | -15.57M | 0 | -14.17M | -16.83M | -15.21M | 0 | 0 | -9.19M |
Repurchases of common stock | 0 | 0 | 2.91M | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 161.87M | 117.02M | -36.63M | -62.48M | 144.60M | 203.73M | -56.98M | -47.31M | -10.12M |
Cash used in financing activities | -12.06M | 244.00M | -166.32M | -199.73M | 35.46M | 323.74M | -95.77M | -23.99M | 7.42M |
Net Change In Cash | 27.08M | 3.74M | 1.64M | -15.77M | -5.13M | -8.60M | 10.59M | 6.15M | 1.67M |
Cash at end of period | 41.95M | 14.87M | 10.23M | 8.58M | -258.16M | 46.34M | 30.26M | 22.30M | 16.14M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |